These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15626474)

  • 1. Predefined spacers between epitopes on a recombinant epitope-peptide impacted epitope-specific antibody response.
    Liu Z; Wang Z; Chen YH
    Immunol Lett; 2005 Feb; 97(1):41-5. PubMed ID: 15626474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELDKWA-epitope-specific monoclonal antibodies inhibit HIV env-mediated syncytium formation.
    Zhang G; Chen YH
    Immunobiology; 2003; 207(4):259-64. PubMed ID: 12952348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1-neutralizing monoclonal antibody 2F5 is multispecific for sequences flanking the DKW core epitope.
    Menendez A; Chow KC; Pan OC; Scott JK
    J Mol Biol; 2004 Apr; 338(2):311-27. PubMed ID: 15066434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of neutralizing epitopes on multiple-epitope vaccines against HIV-1.
    Lu Y; Xiao Y; Ding J; Dierich M; Chen YH
    Int Arch Allergy Immunol; 2000 Jan; 121(1):80-4. PubMed ID: 10686512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The recombinant immunogen with high-density epitopes of ELDKWA and ELDEWA induced antibodies recognizing both epitopes on HIV-1 gp41.
    Wang Z; Liu Z; Cheng X; Chen YH
    Microbiol Immunol; 2005; 49(8):703-9. PubMed ID: 16113499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
    Julien JP; Bryson S; Nieva JL; Pai EF
    J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELNKWA-epitope specific antibodies induced by epitope-vaccine recognize ELDKWA- and other two neutralizing-resistant mutated epitopes on HIV-1 gp41.
    Dong XN; Xiao Y; Chen YH
    Immunol Lett; 2001 Jan; 75(2):149-52. PubMed ID: 11137140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant multi-epitope vaccine induce predefined epitope-specific antibodies against HIV-1.
    Li H; Liu ZQ; Ding J; Chen YH
    Immunol Lett; 2002 Nov; 84(2):153-7. PubMed ID: 12270553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neutralizing epitope ELDKWA on HIV-1 gp41: genetic variability and antigenicity.
    Dong XN; Wu Y; Chen YH
    Immunol Lett; 2005 Oct; 101(1):81-6. PubMed ID: 15951025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A predefined epitope-specific monoclonal antibody recognizes ELDEWA-epitope just presenting on gp41 of HIV-1 O clade.
    Huang J; Dong X; Liu Z; Qin L; Chen YH
    Immunol Lett; 2002 Dec; 84(3):205-9. PubMed ID: 12413738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of high levels of antibodies recognizing the neutralizing epitope ELDKWA and the D- or K-position-mutated epitopes by candidate epitope vaccines against HIV-1.
    Xiao Y; Dong X; Chen Y
    Int Arch Allergy Immunol; 2000 Aug; 122(4):287-92. PubMed ID: 10971120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of monoclonal antibody with predefined ELNKWA epitope specificity by epitope vaccine.
    Xiao Y; Dong XN; Chen YH
    Hybridoma; 2000 Aug; 19(4):347-50. PubMed ID: 11001409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
    Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI
    Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins.
    Liu W; Chen YH
    Eur J Immunol; 2005 Feb; 35(2):505-14. PubMed ID: 15627976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidate multi-epitope vaccines in aluminium adjuvant induce high levels of antibodies with predefined multi-epitope specificity against HIV-1.
    Ding J; Lu Y; Chen Y
    FEMS Immunol Med Microbiol; 2000 Oct; 29(2):123-7. PubMed ID: 11024351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope-vaccine induces high levels of ELDKWA-epitope-specific neutralizing antibody.
    Xiao Y; Zhao Y; Lu Y; Chen YH
    Immunol Invest; 2000 Feb; 29(1):41-50. PubMed ID: 10709845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and specificity of the candidate multi-epitope-vaccines against HIV-1.
    Lu Y; Ding J; Chen YH
    Immunopharmacol Immunotoxicol; 2001 Nov; 23(4):487-94. PubMed ID: 11792008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and purification of epitope peptide of human tyrosinase and its antigenicity in vitiligo patients].
    Guan CP; Zhou MN; Li YW; Wei XD; Xu AE
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2408-11. PubMed ID: 18036319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designed recombinant adenovirus type 5 vector induced envelope-specific CD8(+) cytotoxic T lymphocytes and cross-reactive neutralizing antibodies against human immunodeficiency virus type 1.
    Ura T; Yoshida A; Xin KQ; Yoshizaki S; Yashima S; Abe S; Mizuguchi H; Okuda K
    J Gene Med; 2009 Feb; 11(2):139-49. PubMed ID: 19065543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
    Benferhat R; Martinon F; Krust B; Le Grand R; Hovanessian AG
    Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.